Amedeo Smart

Free Medical Literature Service


 

Amedeo

Prostate Cancer

  Free Subscription

Articles published in
Int J Oncol
    November 2024
  1. IIDA K, Zheng R, Shen R, Nanus DM, et al
    [Corrigendum] Adenoviral neutral endopeptidase gene delivery in combination with paclitaxel for the treatment of prostate cancer.
    Int J Oncol. 2024;65:106.
    >> Share

  2. XU Y, Zhang G, Liu Y, Liu Y, et al
    Molecular mechanisms and targeted therapy for the metastasis of prostate cancer to the bones (Review).
    Int J Oncol. 2024;65:104.
    >> Share

    September 2024
  3. ZHENG XM, Zhang P, Liu MH, Chen P, et al
    [Retracted] MicroRNA?30e inhibits adhesion, migration, invasion and cell cycle progression of prostate cancer cells via inhibition of the activation of the MAPK signaling pathway by downregulating CHRM3.
    Int J Oncol. 2024;65:82.
    >> Share

    February 2024
  4. NAEEM AA, Abdulsamad SA, Zeng H, He G, et al
    FABP5 can substitute for androgen receptor in malignant progression of prostate cancer cells.
    Int J Oncol. 2024;64:18.
    >> Share

  5. ZHONG K, Luo W, Li N, Tan X, et al
    CDK12 regulates angiogenesis of advanced prostate cancer by IGFBP3.
    Int J Oncol. 2024;64:20.
    >> Share

    January 2024
  6. SUN X, Xin S, Zhang Y, Jin L, et al
    [Corrigendum] Long non?coding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway.
    Int J Oncol. 2024;64:5.
    >> Share

    November 2023
  7. FENG K, Liu C, Wang W, Kong P, et al
    Emerging proteins involved in castration?resistant prostate cancer via the AR?dependent and AR?independent pathways (Review).
    Int J Oncol. 2023;63:127.
    >> Share

    June 2023
  8. ZHANG Z, Wang W, Kong P, Feng K, et al
    New insights into lipid metabolism and prostate cancer (Review).
    Int J Oncol. 2023;62:74.
    >> Share

    March 2023
  9. SHI SJ, Han DH, Zhang JL, Li Y, et al
    VIM‑AS1 promotes proliferation and drives enzalutamide resistance in prostate cancer via IGF2BP2‑mediated HMGCS1 mRNA stabilization.
    Int J Oncol. 2023;62:34.
    >> Share

  10. MASUD N, Aldahish A, Iczkowski KA, Kale A, et al
    Zinc finger protein‑like 1 is a novel neuroendocrine biomarker for prostate cancer.
    Int J Oncol. 2023;62:38.
    >> Share

    February 2023
  11. PAN D, Jia Z, Li W, Dou Z, et al
    [Corrigendum] The targeting of MTDH by miR‑145‑5p or miR‑145‑3p is associated with prognosis and regulates the growth and metastasis of prostate cancer cells.
    Int J Oncol. 2023;62:29.
    >> Share

    January 2023
  12. CHEN B, Liu C, Long H, Bai G, et al
    N(6)‑methyladenosine‑induced long non‑coding RNA PVT1 regulates the miR‑27b‑3p/BLM axis to promote prostate cancer progression.
    Int J Oncol. 2023;62:16.
    >> Share

    September 2022
  13. SUN X, Xin S, Zhang Y, Jin L, et al
    Long noncoding RNA CASC11 interacts with YBX1 to promote prostate cancer progression by suppressing the p53 pathway.
    Int J Oncol. 2022;61.
    >> Share

    June 2022
  14. GOULIELMAKI M, Davanos N, Kogionou P, Batsaki P, et al
    The impact of radiation therapy on the TCR Vbeta chain repertoire in patients with prostate cancer.
    Int J Oncol. 2022;60.
    >> Share

    May 2022
  15. CAO J, Chan WC, Chow MSS
    Use of conditional reprogramming cell, patient derived xenograft and organoid for drug screening for individualized prostate cancer therapy: Current and future perspectives (Review).
    Int J Oncol. 2022;60.
    >> Share

    April 2022
  16. HE Z, Gao Y, Li T, Yu C, et al
    HepaCAMPIK3CA axis regulates the reprogramming of glutamine metabolism to inhibit prostate cancer cell proliferation.
    Int J Oncol. 2022;60.
    >> Share

    December 2021
  17. PAN XW, Gan SS, Ye JQ, Fan YH, et al
    [Corrigendum] SMC1A promotes growth and migration of prostate cancer in vitro and in vivo.
    Int J Oncol. 2021;59.
    >> Share

    July 2021
  18. LU S, Dong Z
    Proliferating cell nuclear antigen directly interacts with androgen receptor and enhances androgen receptormediated signaling.
    Int J Oncol. 2021;59.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016